Advanced company searchLink opens in new window

GENFLOW BIOSCIENCES PLC

Company number 13138531

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
02 Jul 2024 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
01 Jul 2024 AA Group of companies' accounts made up to 31 December 2023
09 Apr 2024 SH01 Statement of capital following an allotment of shares on 9 April 2024
  • GBP 104,911.9854
07 Feb 2024 CS01 Confirmation statement made on 17 January 2024 with no updates
26 Jun 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
15 Jun 2023 AA Group of companies' accounts made up to 31 December 2022
22 Mar 2023 AD01 Registered office address changed from 6 Heddon Street London W1B 4BT England to 6 Heddon Street London W1B 4BT on 22 March 2023
22 Mar 2023 AD01 Registered office address changed from Suite 1, 15 Ingestre Place London W1F 0DU England to 6 Heddon Street London W1B 4BT on 22 March 2023
02 Feb 2023 CS01 Confirmation statement made on 17 January 2023 with no updates
08 Aug 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
25 Jul 2022 AP01 Appointment of Ms Tamara Joseph as a director on 29 June 2022
25 Jul 2022 AP01 Appointment of Mr Guy-Charles Fanneau De La Horie as a director on 29 June 2022
25 Jul 2022 TM01 Termination of appointment of Gabrielle Silver as a director on 29 June 2022
25 Jul 2022 TM01 Termination of appointment of Andrew Scott as a director on 29 June 2022
05 Jul 2022 AA Group of companies' accounts made up to 31 December 2021
17 Feb 2022 CS01 Confirmation statement made on 17 January 2022 with updates
04 Feb 2022 SH01 Statement of capital following an allotment of shares on 11 January 2022
  • GBP 87,751.99
24 Jan 2022 RP04AP01 Second filing for the appointment of Dr Gabrielle Silver as a director
24 Jan 2022 RP04AP01 Second filing for the appointment of Dr Andrew Scott as a director
24 Jan 2022 RP04AP01 Second filing for the appointment of Dr Peter William King-Lewis as a director
20 Jan 2022 AP01 Appointment of Professor Andrew Scott as a director on 6 January 2022
  • ANNOTATION Clarification a second filed AP01 was registered on 24/01/22
20 Jan 2022 AP01 Appointment of Dr Peter William King-Lewis as a director on 6 January 2022
  • ANNOTATION Clarification a second filed AP01 was registered on 24/01/22
20 Jan 2022 AP01 Appointment of Dr Gabrielle Alison Silver as a director on 6 January 2022
  • ANNOTATION Clarification a second filed AP01 was registered on 24/01/22
10 Nov 2021 AA01 Current accounting period shortened from 31 January 2022 to 31 December 2021
10 Nov 2021 SH01 Statement of capital following an allotment of shares on 9 November 2021
  • GBP 73,371.04